To assist BASF in the establishment of a registry of workers involved in nanotechnology.
The initial step was a complete inventory of nanomaterials and sites of use. Guidance was developed to clarify which particulate nanomaterials were to be included in the survey. Site management was then contacted by the medical department to obtain a list of workers.
The time line for collecting data ranged from several months to a year, depending on the information needed, and presented challenges based on the lack of global definition and labeling of nanomaterials. Less than 50 nanomaterials are used as raw materials in less than 10% of the sites globally. In North America, less than 5% of sites and 5% workers use nanomaterials.
Further work is required to integrate the inventory, registry, and exposure assessments.
From the BASF Corporation, Florham Park, NJ (Drs David and Conner); and BASF SE, Ludwigshafen, Germany (Drs Nasterlack and Engel).
Address correspondence to: Raymond M. David, PhD, BASF Corporation, 100 Campus Dr, Florham Park, NJ 07932; E-mail: firstname.lastname@example.org.